National Cancer Center, Korea
Clinical trials sponsored by National Cancer Center, Korea, explained in plain language.
-
New drug trial offers hope for advanced liver cancer patients
Disease control Not yet recruitingThis study is testing whether the drug lenvatinib can help control advanced liver cancer in patients who aren't eligible for surgery or transplants. Fifty participants with moderately severe liver damage will take the oral medication daily until their cancer worsens or side effec…
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Can a simple home workout fight Chemo's numbness and pain?
Symptom relief Not yet recruitingThis study is testing whether a structured home exercise program can reduce nerve pain and numbness caused by common chemotherapy drugs. It will involve 140 patients with colorectal or gynecologic cancers who are starting treatment with oxaliplatin or paclitaxel. Half will follow…
Phase: NA • Sponsor: National Cancer Center, Korea • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC